13D Filing: Aisling Capital III LP and Agile Therapeutics Inc (AGRX)

Page 3 of 11

Page 3 of 11 – SEC Filing

CUSIP No. 00847L100
SCHEDULE 13D
Page 3 of 11

1
NAME OF REPORTING PERSON OR
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Aisling Capital Partners III, LP
2
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)  o
(b)  x
3
SEC USE ONLY
4
SOURCE OF FUNDS
OO
5
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
o
6
CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY EACH
REPORTING PERSON
WITH
7
SOLE VOTING POWER
1,304,933
8
SHARED VOTING POWER
0
9
SOLE DISPOSITIVE POWER
1,304,933
10
SHARED DISPOSITIVE POWER
0
11
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,304,933
12
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES
o
13
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.8% (See Item 5)
14
TYPE OF REPORTING PERSON
PN

Follow Agile Therapeutics Inc (NASDAQ:AGRX)

Page 3 of 11